Showing results (391-400 of 537) with videos related to

Sort By:
Pageof 54
RMD Open|February 23, 2025
Targeting the IL-17A pathway for therapy in early-stage tendinopathyNeal L Millar, Iain B McInnes, Frank Kolbinger, et al.
Annals of the Rheumatic Diseases|February 9, 2020
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritisAndreas Kerschbaumer, Alexandre Sepriano, Josef S Smolen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2009
Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma productionHenrique P Lemos, Renata Grespan, Silvio M Vieira, et al.
Arthritis Research & Therapy|December 6, 2019
Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studiesLaura C Coates, Johan K Wallman, Dennis McGonagle, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 25, 2026
Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From the Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept AFFINITY StudyJose U Scher, Iain B McInnes, Enrique R Soriano, et al.
Circulation. Heart Failure|March 19, 2013
Galectin-3 and cardiac function in survivors of acute myocardial infarctionRobin A P Weir, Colin J Petrie, C Aengus Murphy, et al.
Nature Communications|September 28, 2016
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritisStefano Alivernini, Mariola Kurowska-Stolarska, Barbara Tolusso, et al.
Annals of the Rheumatic Diseases|September 15, 2012
Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumabCarrie L Wagner, Sudha Visvanathan, Michael Elashoff, et al.
Frontiers in Immunology|April 30, 2024
IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapyJames G Krueger, Kilian Eyerich, Vijay K Kuchroo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 31, 2018
Characterization and Changes of Lymphocyte Subsets in Baricitinib-Treated Patients With Rheumatoid Arthritis: An Integrated AnalysisYoshiya Tanaka, Iain B McInnes, Peter C Taylor, et al.
Pageof 54